Protalix BioTherapeutics Inc (PLX)
1.67
-0.02
(-1.18%)
USD |
NYAM |
Nov 21, 16:00
1.65
-0.02
(-1.20%)
After-Hours: 20:00
Protalix BioTherapeutics Price to Book Value: 3.791 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.836 |
| November 19, 2024 | 3.700 |
| November 18, 2024 | 3.768 |
| November 15, 2024 | 3.178 |
| November 14, 2024 | 3.201 |
| November 13, 2024 | 2.815 |
| November 12, 2024 | 2.996 |
| November 11, 2024 | 2.724 |
| November 08, 2024 | 2.633 |
| November 07, 2024 | 2.633 |
| November 06, 2024 | 2.770 |
| November 05, 2024 | 2.951 |
| November 04, 2024 | 2.906 |
| November 01, 2024 | 2.838 |
| October 31, 2024 | 2.656 |
| October 30, 2024 | 2.656 |
| October 29, 2024 | 2.656 |
| October 28, 2024 | 2.565 |
| October 25, 2024 | 2.452 |
| October 24, 2024 | 2.338 |
| October 23, 2024 | 2.316 |
| October 22, 2024 | 2.406 |
| October 21, 2024 | 2.406 |
| October 18, 2024 | 2.474 |
| October 17, 2024 | 2.474 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.474 |
| October 15, 2024 | 2.452 |
| October 14, 2024 | 2.406 |
| October 11, 2024 | 2.452 |
| October 10, 2024 | 2.270 |
| October 09, 2024 | 2.293 |
| October 08, 2024 | 2.316 |
| October 07, 2024 | 2.316 |
| October 04, 2024 | 2.452 |
| October 03, 2024 | 2.293 |
| October 02, 2024 | 2.316 |
| October 01, 2024 | 2.384 |
| September 30, 2024 | 2.316 |
| September 27, 2024 | 2.702 |
| September 26, 2024 | 2.753 |
| September 25, 2024 | 2.805 |
| September 24, 2024 | 2.779 |
| September 23, 2024 | 2.882 |
| September 20, 2024 | 2.830 |
| September 19, 2024 | 2.959 |
| September 18, 2024 | 2.805 |
| September 17, 2024 | 2.830 |
| September 16, 2024 | 2.805 |
| September 13, 2024 | 2.702 |
| September 12, 2024 | 2.728 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.270
Minimum
Oct 10 2024
284.46
Maximum
Sep 30 2021
44.43
Average
3.372
Median
Price to Book Value Benchmarks
| Accuray Inc | 4.214 |
| Aethlon Medical Inc | 0.8907 |
| AIM ImmunoTech Inc | 4.627 |
| Perspective Therapeutics Inc | 0.6153 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.872 |
| Price to Free Cash Flow | 18.29 |
| Price | 1.67 |
| Earnings Yield | -9.58% |
| Market Cap | 122.97M |